ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Novartis receives European Commission approval for self-administration of Xolair? across all indications
en-cphi.cn
December 14, 2018Novartis today announced that the European Commission (EC) has approved Xolair? (omalizumab) prefilled syringe (PFS) for self-administration, allowing patients with severe allergic asthma (SAA) and chronic spontaneous urticaria (CSU) to administer their o
Pharma Sources Insight January 2025
